| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Non-Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Name | Rivaroxaban Intermediate |
| CAS | 446292-10-0 |
| MF | C14H17N3O4 |
| MW | 291.3 |
| EINECS | 692-970-2 |
| Appearance | White powder |
| Categories | Intermediate;Anti-coagulant;Pharmaceutical |
| Uses | Rivaroxaban is an orally active, direct inhibitor which is a crucial component of the intrinsic and extrinsic pathways of the blood coagulation cascade. Rivaroxaban is reported to inhibit thrombin formation without prolonging bleeding time and has been approved for clinical use as an anticoagulant in the prevention of stroke and the treatment of venous thromboembolisms. |
| Rivaroxaban is an orally active, direct inhibitor which is a crucial component of the intrinsic and extrinsic pathways of the blood coagulation cascade. Rivaroxaban is reported to inhibit thrombin formation without prolonging bleeding time and has been approved for clinical use as an anticoagulant in the prevention of stroke and the treatment of venous thromboembolisms. |
){kind=link}